Tacrolimus-based immunosuppression in pediatric renal transplantation.
Jordan
M L
ML
Division of Urologic Surgery/Transplantation and Starzl Transplantation Institute, University of Pittsburgh Medical Center, PA 15213, USA.
Shapiro
R
R
Scantlebury
V
V
Vivas
C
C
Ellis
D
D
Lombardozzi-Lane
S
S
Starzl
T E
TE
D000206:Actuarial Analysis; D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D003404:Creatinine / Q000097:blood; D003586:Cytomegalovirus Infections / Q000453:epidemiology; D006084:Graft Rejection / Q000453:epidemiology / Q000517:prevention & control; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015994:Incidence; D007223:Infant; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D019520:Living Donors; D008875:Middle Aged; D012086:Reoperation; D012189:Retrospective Studies; D015996:Survival Rate; D016559:Tacrolimus / Q000627:therapeutic use*; D014019:Tissue Donors
D007166:Immunosuppressive Agents; D003404:Creatinine; D016559:Tacrolimus